Moving from GWAS signals to rare functional variation in inflammatory bowel disease through application of GenePy2 as a potential DNA biomarker

Guo Cheng, James J Ashton, Andrew Collins, R Mark Beattie, Sarah Ennis
doi: https://doi.org/10.1101/2024.04.19.24306093

Article Information

doi 
https://doi.org/10.1101/2024.04.19.24306093
History 
  • April 20, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Guo Cheng1,3,
  2. James J Ashton1,2,
  3. Andrew Collins,
  4. R Mark Beattie2 and
  5. Sarah Ennis1,3,*
  1. 1Human Genetics and Genomic Medicine, Faculty of Medicine, University of Southampton, Southampton, UK
  2. 2Department of Paediatric Gastroenterology, Southampton Children’s Hospital, Southampton, UK
  3. 3NIHR Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, UK
  1. ↵*Correspondence to: Professor Sarah Ennis, Human Genetics & Genomic Medicine, University of Southampton Duthie Building (Mailpoint 808), University Hospital Southampton, Southampton, SO16 6YD, United Kingdom, Tel: +44 (0)23 8079 8614, s.ennis{at}southampton.ac.uk
Back to top
Posted April 20, 2024.
Download PDF

Supplementary Material

Data/Code
Email
Moving from GWAS signals to rare functional variation in inflammatory bowel disease through application of GenePy2 as a potential DNA biomarker
Guo Cheng, James J Ashton, Andrew Collins, R Mark Beattie, Sarah Ennis
medRxiv 2024.04.19.24306093; doi: https://doi.org/10.1101/2024.04.19.24306093
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area